Skip Header

15 results for author:"Kristoffersson U." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (5)

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer
Jakubowska A., Rozkrut D., Antoniou A., Hamann U., Scott R.J., McGuffog L., Healy S., Sinilnikova O.M., Rennert G., Lejbkowicz F. et al.

Br. J. Cancer 106:2016-2024(2012) · Mapped (13)

Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.

Magnusson S., Gisselsson D., Wiebe T., Kristoffersson U., Borg A., Olsson H.

Pediatr Blood Cancer 59:846-853(2012) · Mapped (32)

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Bolton K.L., Chenevix-Trench G., Goh C., Sadetzki S., Ramus S.J., Karlan B.Y., Lambrechts D., Despierre E., Barrowdale D., McGuffog L. et al.

JAMA 307:382-390(2012) · Mapped (18)

A large-sample assessment of possible association between ischaemic stroke and rs12188950 in the PDE4D gene.

Lovkvist H., Olsson S., Hoglund P., Melander O., Jern C., Sjogren M., Engstrom G., Smith J.G., Hedblad B., Andsberg G. et al.

Eur. J. Hum. Genet. 20:783-789(2012) · Mapped (4)

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.

Walker L.C., Fredericksen Z.S., Wang X., Tarrell R., Pankratz V.S., Lindor N.M., Beesley J., Healey S., Chen X., Stoppa-Lyonnet D. et al.

Breast Cancer Res. 12:R102-R102(2010) · Mapped (6)

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
Engel C., Versmold B., Wappenschmidt B., Simard J., Easton D.F., Peock S., Cook M., Oliver C., Frost D., Mayes R. et al.

Cancer Epidemiol. Biomarkers Prev. 19:2859-2868(2010) · Mapped (21)

No evidence that GATA3 rs570613 SNP modifies breast cancer risk.

Breast Cancer Association Consortium and Consortium of Investigators of Modifiers of BRCA1/2
Johnatty S.E., Couch F.J., Fredericksen Z., Tarrell R., Spurdle A.B., Beesley J., Chen X., Gschwantler-Kaulich D., Singer C.F., Fuerhauser C. et al.

Breast Cancer Res. Treat. 117:371-379(2009) · Mapped (55)

Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72.

Nilbert M., Kristoffersson U., Ericsson M., Johannsson O., Rambech E., Mangell P.

BMC Med. Genet. 9:101-101(2008) · Mapped (10)

Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes.

Magnusson S., Borg A., Kristoffersson U., Nilbert M., Wiebe T., Olsson H.

Fam. Cancer 7:331-337(2008) · Mapped (66)

Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region.

Lovkvist H., Smith J.G., Luthman H., Hoglund P., Norrving B., Kristoffersson U., Jonsson A.C., Lindgren A.G.

Eur. J. Hum. Genet. 16:1117-1125(2008) · Mapped (14)

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.

Malander S., Ridderheim M., Masbaeck A., Loman N., Kristoffersson U., Olsson H., Nilbert M., Borg A.

Eur. J. Cancer 40:422-428(2004) · UniProtKB (2) · Mapped (17)

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Carpten J.D., Robbins C.M., Villablanca A., Forsberg L., Presciuttini S., Bailey-Wilson J., Simonds W.F., Gillanders E.M., Kennedy A.M., Chen J.D. et al.

Nat. Genet. 32:676-680(2002) · UniProtKB (1) · Mapped (3)

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

Loman N., Johannsson O., Kristoffersson U., Olsson H., Borg A.

J. Natl. Cancer Inst. 93:1215-1223(2001) · Mapped (18)

Frequency of RET mutations in long- and short-segment Hirschsprung disease.

Seri M., Yin L., Barone V., Bolino A., Celli I., Bocciardi R., Pasini B., Ceccherini I., Lerone M., Kristoffersson U. et al.

Hum. Mutat. 9:243-249(1997) · UniProtKB (1)

Heterogeneity and low detection rate of RET mutations in Hirschsprung disease.

Yin L., Barone V., Seri M., Bolino A., Bocciardi R., Ceccherini I., Pasini B., Tocco T., Lerone M., Cywes S. et al.

Eur. J. Hum. Genet. 2:272-280(1994) · UniProtKB (1)

to top of page·

Page 1 of 1